🇺🇸 FDA
Pipeline program

Cosyntropin

NMCSD.2006.0026

Approved small_molecule completed

Quick answer

Cosyntropin for Postdural Puncture Headache is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Postdural Puncture Headache
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials